The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Roche
 
Honoraria - Bristol-Myers Squibb; Ipsen; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer; Roche
Research Funding - Bayer; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Honoraria - Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL.
 
Martin Boegemann
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Janssen; Novartis
 
Jens Bedke
No Relationships to Disclose
 
Martin Schostak
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca; Bayer; Janssen; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Novartis
 
Manfred Welslau
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - Amgen; Janssen; Novartis; Roche
Speakers' Bureau - Janssen
 
Christiane Hering-Schubert
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Roche
Consulting or Advisory Role - Amgen; Celgene
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene
 
Thomas Wolf
No Relationships to Disclose
 
Jan Schleicher
Honoraria - Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Alexander Petzold
No Relationships to Disclose
 
Christian Doehn
No Relationships to Disclose
 
Carsten Grüllich
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Thomas Steiner
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Eisai (Inst); Novartis (Inst); Pfizer (Inst)
 
Rainer Ehness
Employment - Novartis
Stock and Other Ownership Interests - GlaxoSmithKline; Novartis
 
Dunja Klein
Employment - iOMEDICO
 
Tanja Medinger
Employment - iOMEDICO
 
Peter-Juergen Goebell
No Relationships to Disclose